IFF Bets Big on Innovation with Strategic Divestiture & $2.5B Buyback

NEW YORK, NY – August 04, 2026 – International Flavors & Fragrances Inc. (IFF) is executing a decisive strategic pivot, moving to sharpen its focus on its most innovative and profitable business lines. The company today detailed strong second-quarter 2026 results for its core continuing operations and unveiled a comprehensive plan for the nearly $4 billion in proceeds from the pending divestiture of its Food Ingredients division. The strategy involves significant debt reduction and a substantial $2.5 billion share repurchase program, signaling a new, more streamlined chapter for the industry giant.

A Strategic Slim-Down for Higher Growth

The centerpiece of IFF’s transformation is the definitive agreement to sell its Food Ingredients (FI) business to CVC Capital Partners for net cash proceeds of approximately $3.8 billion. The transaction, expected to close by the second quarter of 2027, marks a crucial step in the company's multi-year effort to optimize its portfolio and concentrate on its higher-growth, higher-margin segments: Taste, Scent, and Health & Biosciences.

This move is not an isolated event but the culmination of a broader strategy that has seen IFF complete 13 non-core divestitures since 2021, generating significant proceeds to reshape its financial profile. The sale of the FI division, which follows the divestiture of the Soy Crush, Concentrates, and Lecithin (SCL) businesses earlier in the year, is the most significant step yet. According to company reports, the divested Food Ingredients business operated at a lower adjusted EBITDA margin—around 12.9% in 2025—compared to the more robust profitability of its core segments, such as Health & Biosciences, which boasts margins closer to 25%.

In a statement, CEO Erik Fyrwald emphasized the strategic rationale, noting the transaction will create "a simpler, higher-growth, higher-margin company with enhanced cash generation." By retaining an approximately 10% minority equity interest in the divested business, IFF maintains a connection for potential collaboration while freeing up immense capital and management focus to drive innovation in its core areas. The company now presents its financials on a continuing operations basis, providing investors with a clearer view of the performance and potential of the reshaped enterprise.

Fortifying the Balance Sheet and Rewarding Shareholders

With the influx of cash from the divestiture, IFF has laid out a disciplined capital allocation framework designed to bolster its financial foundation and deliver direct returns to shareholders. A top priority is debt reduction, with over $1 billion of the net proceeds earmarked to pay down outstanding debt. This move aims to solidify the company's balance sheet and maintain its target leverage ratio in the range of 2.0x to 2.5x net debt to EBITDA. This disciplined approach has already borne fruit, contributing to an S&P Global Ratings upgrade to 'BBB' earlier in the year as the company's leverage profile improved.

Demonstrating deep confidence in its future, IFF's Board of Directors has also authorized an enhanced $2.5 billion share repurchase program. The plan will be executed in two phases: an accelerated $500 million buyback in the second half of 2026, followed by the remaining $2.0 billion after the divestiture closes, with a target completion by the end of 2027. Such a large-scale buyback is a strong signal from management that it believes the company's stock is undervalued and represents a compelling investment, aiming to directly enhance long-term shareholder value.

Core Segments Powering Performance

The strategic pivot is supported by solid performance from the company's continuing operations. Second-quarter results showed reported net sales of $1.95 billion, a 2% increase over the prior-year period. On a comparable, currency-neutral basis, the growth was even stronger at 6%, driven by volume growth and disciplined execution.

Performance was broad-based across the core segments:

• Scent: This segment led the way with an 8% increase in currency-neutral sales, reaching $665 million. Growth was fueled by double-digit performance in Fragrance Ingredients and a high single-digit increase in Consumer Fragrance.

• Health & Biosciences: Sales grew 5% on a currency-neutral basis to $601 million, with strong contributions from Grain Processing, Food Biosciences, and Animal Nutrition. The segment's adjusted operating EBITDA margin stood at a robust 25.0%.

• Taste: The segment posted a 4% currency-neutral sales increase to $688 million, reflecting healthy, broad-based growth across all regions.

Looking ahead, IFF has introduced full-year 2026 guidance for its continuing operations, projecting sales between $7.4 billion and $7.6 billion and adjusted operating EBITDA in the range of $1.53 billion to $1.60 billion. This new guidance provides a transparent baseline for the go-forward company, reinforcing the outlook for its core innovation-led businesses.

Navigating the Transition and Industry Ripple Effects

Divesting a major business unit is not without its complexities. IFF acknowledged it will be left with approximately $100 million in "stranded costs"—corporate expenses previously allocated to the Food Ingredients business. However, management has a clear remediation plan, expecting to eliminate two-thirds of these costs within the first year post-close and substantially all within two years through decisive action and efficiency programs.

Market analysts have largely reacted positively to the strategic clarity, with some viewing this as a potential "profit inflection point" for IFF. The focus on higher-margin businesses is seen as a move that could unlock significant value over the long term. While some observers have noted potential for near-term earnings per share dilution as a result of the divestiture, the consensus is that the long-term benefits of a streamlined portfolio, stronger balance sheet, and enhanced shareholder returns will outweigh these transitional impacts.

The strategic reshaping of IFF is poised to send ripples across the competitive landscape. A more focused and financially agile IFF can invest more aggressively in R&D and strategic initiatives within the high-value areas of flavors, fragrances, and biosciences. This could intensify competition and accelerate innovation across the industry as rivals respond to a formidable competitor doubling down on its core strengths.